UTRS OTC
Minerva Surgical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$50M
-3.5% ▼
3Y CAGR: +24.6%
Gross Profit
$27M
-10.7% ▼
3Y CAGR: +32.1%
Operating Income
-$31M
-6.0% ▼
Net Income
-$34M
-58.9% ▼
EPS (Diluted)
$-23.68
-58.1% ▼
EBITDA
-$20M
-2347.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $26M | $38M | $52M | $50M |
| YoY Growth | +0.0% | +45.2% | +38.0% | -3.5% |
| Cost of Revenue | $14M | $19M | $22M | $23M |
| Gross Profit | $12M | $19M | $31M | $27M |
| Gross Margin | 45.4% | 50.6% | 58.6% | 54.2% |
| R&D Expenses | $935K | $3M | $5M | $5M |
| SG&A Expenses | $31M | $31M | $54M | $53M |
| Operating Expenses | $31M | $35M | $60M | $58M |
| Operating Income | -$20M | -$15M | -$29M | -$31M |
| Operating Margin | -75.5% | -40.7% | -55.9% | -61.4% |
| Interest Expense | $18M | $12M | $12M | $3M |
| Income Before Tax | -$52M | -$18M | -$21M | -$34M |
| Tax Expense | $0 | -$132K | $9K | $11K |
| Net Income | -$52M | -$18M | -$21M | -$34M |
| Net Margin | -200.1% | -48.4% | -41.2% | -67.8% |
| EPS (Diluted) | $-75.29 | $-17.91 | $-14.98 | $-23.68 |
| EBITDA | -$18M | $821K | $893K | -$20M |
| Shares Outstanding | 927034 | 1M | 1M | 1M |